NCT03748758View on ClinicalTrials.gov

Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

March 20, 2019

Study Completion Date

March 20, 2019

Conditions
Healthy Adult Volunteers
Interventions
COMBINATION_PRODUCT

Drug: OP0201

Drug OP0201

COMBINATION_PRODUCT

Drug: Placebo

Placebo

Trial Locations (1)

66212

Vince and Associates, Overland Park

Sponsors
All Listed Sponsors
lead

Novus Therapeutics, Inc

INDUSTRY